Clinical trial
Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
NCT01233635 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
- Lead sponsor
- University of Pittsburgh
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- November 30, 2007
- Enrollment
- 228 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.